A team from the National Physical Laboratory in the U.K. identified a tiny fragment of the protein and re-engineered it to produce “virus-like capsules” that are able to target bacteria but leave other cells unaffected.
“Antimicrobial resistance is an increasing public health threat which requires a strong and coordinated response,” Jason Crain, director of research at NPL, said in a statement. “This work demonstrates the power of combining physics and engineering principles with innovative measurement methods to create new strategies for tackling the problem. It is exactly the sort of high priority problem that the National Physical Laboratory should be active in addressing in collaboration with others.”
More articles on infection control:
Zika update: Spread warning, travel alerts, pregnancy recommendations
Baystate hospital warns nearly 300 patients of infection risk from dirty scope
More than 80 drugmakers, stakeholders demand worldwide government action on antibiotic resistance
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
